Hershey Trust Company’s Aligos Therapeutics ALGS Stock Holding History

Hershey Trust Company’s Portfolio ALGS Stock Details ALGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-182	Closed	-$6K	–	17
2022 Q2	$6K	Hold	182	–	–	﹤0.01%	34
2022 Q1	$10K	Sell	182 -61	-25%	-$4.88K	﹤0.01%	32
2021 Q4	$72K	Hold	243	–	–	﹤0.01%	38
2021 Q3	$94K	Hold	243	–	–	﹤0.01%	29
2021 Q2	$124K	Buy	+243	New	+$155K	﹤0.01%	31

Other funds holding ALGS

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hershey Trust Company's ALGS Position: Q3 2022 in Review

Hershey Trust Company sold out of Aligos Therapeutics (ALGS) in Q3 2022, closing a stake of 182 shares — an estimated $6K sold.

Hershey Trust Company first reported a position in ALGS in Q2 2021 and held it in 5 quarters. The position peaked at $124K in Q2 2021. 52 funds tracked by Wall St. Rank hold ALGS as of Q3 2022.

Hershey Trust Company reported no remaining Aligos Therapeutics position as of Q3 2022 after selling out during the quarter.
Hershey Trust Company sold 182 Aligos Therapeutics shares in Q3 2022, an estimated $6K.
Hershey Trust Company first reported a position in Aligos Therapeutics in Q2 2021 and held it in 5 quarters.
Hershey Trust Company's Aligos Therapeutics position peaked at $124K in Q2 2021.
52 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q3 2022.

Based on Hershey Trust Company's 13F filing for Q3 2022, filed 15 Nov 2022.